Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 23114457)

1.

Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries.

Clay E, Falissard B, Moore N, Toumi M.

Eur J Clin Pharmacol. 2013 Apr;69(4):1-10. doi: 10.1007/s00228-012-1424-1. Epub 2012 Nov 1.

2.

Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database.

Kunz D, Bineau S, Maman K, Milea D, Toumi M.

Expert Opin Pharmacother. 2012 Jan;13(1):9-16. doi: 10.1517/14656566.2012.638284. Epub 2011 Nov 22.

PMID:
22107732
3.

Sleep complaints: Whenever possible, avoid the use of sleeping pills.

[No authors listed]

Prescrire Int. 2008 Oct;17(97):206-12.

PMID:
19536941
4.

Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.

Dündar Y, Boland A, Strobl J, Dodd S, Haycox A, Bagust A, Bogg J, Dickson R, Walley T.

Health Technol Assess. 2004 Jun;8(24):iii-x, 1-125. Review.

5.

Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages.

Bourgeois J, Elseviers MM, Azermai M, Van Bortel L, Petrovic M, Vander Stichele RR.

Eur J Clin Pharmacol. 2012 May;68(5):833-44. doi: 10.1007/s00228-011-1188-z. Epub 2011 Dec 22.

PMID:
22189673
6.

Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors.

Hausken AM, Furu K, Skurtveit S, Engeland A, Bramness JG.

Eur J Clin Pharmacol. 2009 Mar;65(3):295-301. doi: 10.1007/s00228-008-0565-8. Epub 2008 Sep 23.

PMID:
18810397
7.

Prolonged-release melatonin for the treatment of insomnia in patients over 55 years.

Wade A, Downie S.

Expert Opin Investig Drugs. 2008 Oct;17(10):1567-72. doi: 10.1517/13543784.17.10.1567 . Review.

PMID:
18808316
8.

Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial.

Lähteenmäki R, Puustinen J, Vahlberg T, Lyles A, Neuvonen PJ, Partinen M, Räihä I, Kivelä SL.

Br J Clin Pharmacol. 2014 Jun;77(6):975-85. doi: 10.1111/bcp.12294.

9.

Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review.

Allain H, Bentué-Ferrer D, Polard E, Akwa Y, Patat A.

Drugs Aging. 2005;22(9):749-65. Review.

PMID:
16156679
10.

Safety of zaleplon in the treatment of insomnia.

Israel AG, Kramer JA.

Ann Pharmacother. 2002 May;36(5):852-9. Review.

PMID:
11978165
11.

Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?

Srinivasan V, Brzezinski A, Pandi-Perumal SR, Spence DW, Cardinali DP, Brown GM.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):913-23. doi: 10.1016/j.pnpbp.2011.03.013. Epub 2011 Mar 29. Review.

PMID:
21453740
12.

Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia.

Wagner J, Wagner ML, Hening WA.

Ann Pharmacother. 1998 Jun;32(6):680-91. Review.

PMID:
9640488
13.

Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years.

Lyseng-Williamson KA.

Drugs Aging. 2012 Nov;29(11):911-23. doi: 10.1007/s40266-012-0018-z. Review.

PMID:
23044640
14.

Management of chronic insomnia in elderly persons.

Bain KT.

Am J Geriatr Pharmacother. 2006 Jun;4(2):168-92. Review.

PMID:
16860264
15.

Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol.

Baandrup L, Fagerlund B, Jennum P, Lublin H, Hansen JL, Winkel P, Gluud C, Oranje B, Glenthoj BY.

BMC Psychiatry. 2011 Oct 5;11:160. doi: 10.1186/1471-244X-11-160.

16.

Main neuroendocrine features and therapy in primary sleep troubles.

Amihăesei IC, Mungiu OC.

Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):862-6.

PMID:
23272543
18.

Some implications of melatonin use in chronopharmacology of insomnia.

Golombek DA, Pandi-Perumal SR, Brown GM, Cardinali DP.

Eur J Pharmacol. 2015 May 21;762:42-48. doi: 10.1016/j.ejphar.2015.05.032. [Epub ahead of print]

PMID:
26004526
19.

[Are z-hypnotics better and safer sleeping pills than benzodiazepines?].

Mellingsaeter TC, Bramness JG, Slørdal L.

Tidsskr Nor Laegeforen. 2006 Nov 16;126(22):2954-6. Norwegian.

20.

Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia.

Lemoine P, Zisapel N.

Expert Opin Pharmacother. 2012 Apr;13(6):895-905. doi: 10.1517/14656566.2012.667076. Epub 2012 Mar 19. Review.

PMID:
22429105
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk